Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 17, 2019

SELL
$250.96 - $284.94 $683,615 - $776,176
-2,724 Closed
0 $0
Q1 2019

Oct 17, 2019

BUY
$276.39 - $362.25 $752,886 - $986,769
2,724 New
2,724 $778,000
Q3 2018

Oct 05, 2018

SELL
$354.53 - $449.75 $763,303 - $968,311
-2,153 Closed
0 $0
Q2 2018

Jul 17, 2018

BUY
$278.07 - $446.21 $598,684 - $960,690
2,153 New
2,153 $881,000
Q1 2018

Apr 17, 2018

SELL
$192.49 - $295.85 $323,190 - $496,732
-1,679 Closed
0 $0
Q4 2017

Jan 18, 2018

BUY
$168.78 - $199.74 $283,381 - $335,363
1,679
1,679 $315,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Fox Run Management, L.L.C. Portfolio

Follow Fox Run Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fox Run Management, L.L.C. with notifications on news.